PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients

Clinical trial NCT06762405 · RECRUITING

Trial details

NCT number: NCT06762405
Sponsor: Centre Hospitalier Universitaire Dijon
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Start date: 2025-02-06
Primary completion: 2030-09-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.